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Abstract
Well documented side effects of ketamine include altered mental status, 
and cardiovascular and respiratory toxicities. A new clinical entity termed 
ketamine-associated ulcerative cystitis characterized by irritative lower 
urinary tract symptoms has been reported recently. We report a case of 
ketamine-associated ulcerative cystitis in a 25-year-old man. He suffered 
progressive, painful hematuria, dysuria and suprapubic pain several days 
after beginning ketamine abuse. His symptoms aggravated over the next 
6 months and imaging studies confirmed a contractile urinary bladder with 
bilateral hydronephrosis and hydroureter. Although there was partial relief 
of his symptoms after cessation of ketamine abuse, he now requires regu-
lar hemodialysis for end-stage renal disease. [Tzu Chi Med J 2008;20(2):
144–146]
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1. Introduction
Ketamine, a derivative of phencyclidine hydrochloride, 
interferes with excitatory amino acids including gluta-
mate and aspartate. It is a noncompetitive N-methyl-D-
aspartate receptor antagonist introduced in the 1960s 
as a dissociative anesthetic [1–4]. Ketamine also inter-
acts with muscarinic, nicotinic, cholinergic and opioid 
receptors inhibiting the neuronal uptake of norepi-
nephrine, dopamine and serotonin [2,4]. Ketamine has 
been more widely used as a recreational drug in night-
clubs, dance parties and “raves” since the 1980s, and 
its street names include special K, K, kit-kat, keets, 
super acid, super K, and jet [1–3,5–7]. Reported side 
effects include altered mental status, and cardiovas-
cular and respiratory toxicities [1–5].
A new clinical entity termed ketamine-associated 
ulcerative cystitis and characterized by irritative lower 
urinary tract symptoms related to ketamine use among 
young adults has been reported recently [1]. The diag-
nosis is mainly based on ketamine-related symptoms 
involving a combination of irritative voiding symp-
toms, hematuria, suprapubic pain and erythematous 
bladder lesions [1,7]. The reported mean age is 25, 
with a male dominance. Bilateral hydronephrosis was 
found in most cases [7]. Although the mechanism 
of ketamine-associated ulcerative cystitis remains 
unclear, variable degrees of eosinophilic infiltrates 
noted in four reported cases with bladder biopsy re-
sults suggest a complement-related disorder [8]. Thus, 
we report a case of ketamine-associated ulcerative 
cystitis because of the potential for under-diagnosis 
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and because of the growing incidence of ketamine 
abuse.
2. Case report
A 25-year-old man presented with painful hematuria, 
dysuria and suprapubic pain. He smoked half a pack 
of cigarettes per day and his history was unremarkable. 
Urine cultures, urinalysis and urine cytology were nor-
mal except for 20–30 red blood cells per high power 
field. The initial intravenous pyelography (IVP) showed 
no abnormal results. Cystoscopy revealed edematous 
mucosal changes (Fig. 1). The patient received con-
servative treatment with regular clinical follow-up.
His symptoms persisted and aggravated over the 
next 6 months. He revealed a previously concealed 
history of ketamine abuse. The drugs, which he bought 
in night clubs, were white powders which he dissolved 
in normal saline and took via intravenous injection 
about two to three times a week. His symptoms began 
just several days after the onset of ketamine use. His 
blood analysis was normal except for eosinophilia 
(4.1%). IVP showed a contracted urinary bladder, nar-
rowing of bilateral cystoureteral junctions, bilateral 
hydroureters and bilateral hydronephrosis (Fig. 2). 
Computed tomography revealed a small urinary blad-
der with irregular wall thickening (Fig. 3). Partial relief 
of his symptoms was noted after cessation of keta-
mine use. However, after 3 months, the patient re-
quired regular hemodialysis due to end-stage renal 
disease.
3. Discussion
We reported a case of ketamine-associated ulcerative 
cystitis in our institution. This is a new clinical entity 
that has been identified recently and the diagnosis is 
mainly based on ketamine-related symptoms involv-
ing a combination of irritative voiding symptoms, 
Fig. 1 — Cystography reveals nonspecific mucosal ede-
matous changes in the urinary bladder.
A B
Fig. 2 — (A) Intravenous pyelography 6 months after initial presentation reveals a contracted urinary bladder, narrow-
ing of bilateral cystoureteral junctions (arrows), bilateral hydroureters and bilateral hydronephrosis 40 minutes after 
contrast media injection. (B) Previous pyelography 6 months before reveals no abnormal findings.
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hematuria, suprapubic pain and erythematous blad-
der lesions [1,7]. The strong temporal association of 
painful hematuria, dysuria and suprapubic pain in our 
patient observed between the onset and cessation of 
ketamine use implicated the diagnosis. His cystographic 
and imaging findings also suggested the diagnosis.
Our patient was a 25-year-old man with bilateral 
hydronephrosis. Chu et al reported 10 patients with 
ketamine-associated ulcerative cystitis characterized 
by male dominance (70%) with a mean age of 25 years; 
bilateral hydronephrosis was noted in eight cases [7]. 
However, they reported abnormal elevation of alkaline 
phosphatase and alanine aminotransferase in all 10 
cases, but this was not present in our patient. Shahani 
et al reported variable degrees of eosinophilic infil-
trates in all of four cases with bladder biopsy [1]. 
Although a bladder biopsy was not performed, the 
eosinophilia in our patient may resemble this finding 
to some extent. Cystitis with eosinophilic infiltration 
on histology is termed eosinophilic cystitis and was 
first reported in 1960 by Brown and Palubinskas [1,8]. 
Eosinophilic cystitis shares a clinical presentation sim-
ilar to ketamine-associated ulcerative cystitis and thus 
they may have a common mechanism of complement-
related irritation of the uroepithelium.
Ketamine is clinically used as a short-acting, general 
anesthetic for pediatric anesthesia [1–7]. It has been 
more widely used as a recreational drug in night-
clubs since the 1980s [1,3,5–7]. Well documented 
side effects include altered mental status, and car-
diovascular and respiratory toxicities [1–5]. It is a com-
monly abused drug and at least 70% of emergency 
room visits for drug abuse in young adults have been 
attributed to ketamine abuse [2,7]. Thus, clinicians 
should be aware of these newly reported urinary side 
effects.
At the present time, the recommended treatment 
for ketamine-associated ulcerative cystitis includes 
cessation of ketamine use, possibly combined with 
administration of pentosan polysulfate [1]. However, 
as in our patient, symptoms in some cases may not 
completely resolve with cessation of ketamine use and 
chronic cystitis may occur [1,7]. Clinicians should be 
ready to manage this new clinical entity because of 
the potential for under-diagnosis and because of the 
growing incidence of ketamine abuse.
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Fig. 3 — Non-enhanced transverse computed tomography 
reveals a reduced cavity and irregular wall thickening in 
the urinary bladder (arrow).
